Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Comment by beenthereon Jun 22, 2021 9:45pm
136 Views
Post# 33432127

RE:RE:Convertible Security Funding Agreement

RE:RE:Convertible Security Funding Agreement Good or Bad?
Does it really matter?

As with ALL of news releases with BTI it's always to do with money!
( Don't believe? Go check back the last 2 years)

It doesn'tt do anything for us but it does make sure our part time ceo gets paid and my guess a bonus for all her hard work!!
Unreal!
<< Previous
Bullboard Posts
Next >>